Putnam Investments’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-20,332
| Closed | -$2.46M | – | 1219 |
|
|
2023
Q3 | $2.46M | Sell |
20,332
-34,388
| -63% | -$4.17M | ﹤0.01% | 678 |
|
|
2023
Q2 | $6.27M | Sell |
54,720
-27,930
| -34% | -$3.2M | 0.01% | 408 |
|
|
2023
Q1 | $11.4M | Sell |
82,650
-24,668
| -23% | -$3.4M | 0.02% | 286 |
|
|
2022
Q4 | $13.9M | Sell |
107,318
-7
| -0% | -$907 | 0.02% | 242 |
|
|
2022
Q3 | $11.9M | Buy |
107,325
+50,725
| +90% | +$5.61M | 0.02% | 262 |
|
|
2022
Q2 | $4.24M | Buy |
+56,600
| New | +$4.24M | 0.01% | 479 |
|
|
2021
Q1 | – | Sell |
-38,560
| Closed | -$6.57M | – | 839 |
|
|
2020
Q4 | $6.57M | Sell |
38,560
-1,129
| -3% | -$192K | 0.01% | 452 |
|
|
2020
Q3 | $5.57M | Sell |
39,689
-28,957
| -42% | -$4.07M | 0.01% | 460 |
|
|
2020
Q2 | $11M | Sell |
68,646
-50,854
| -43% | -$8.15M | 0.02% | 313 |
|
|
2020
Q1 | $11.7M | Buy |
119,500
+41,200
| +53% | +$4.03M | 0.03% | 288 |
|
|
2019
Q4 | $10.1M | Buy |
+78,300
| New | +$10.1M | 0.02% | 364 |
|
|
2019
Q3 | – | Sell |
-29,438
| Closed | -$4.47M | – | 939 |
|
|
2019
Q2 | $4.47M | Sell |
29,438
-953
| -3% | -$145K | 0.01% | 542 |
|
|
2019
Q1 | $3.62M | Sell |
30,391
-2,769
| -8% | -$330K | 0.01% | 595 |
|
|
2018
Q4 | $3.62M | Hold |
33,160
| – | – | 0.01% | 525 |
|
|
2018
Q3 | $5.36M | Buy |
33,160
+18,312
| +123% | +$2.96M | 0.01% | 547 |
|
|
2018
Q2 | $1.96M | Sell |
14,848
-8,984
| -38% | -$1.19M | ﹤0.01% | 727 |
|
|
2018
Q1 | $1.77M | Buy |
23,832
+1,100
| +5% | +$81.5K | ﹤0.01% | 741 |
|
|
2017
Q4 | $1.26M | Buy |
22,732
+5,358
| +31% | +$298K | ﹤0.01% | 855 |
|
|
2017
Q3 | $788K | Buy |
+17,374
| New | +$788K | ﹤0.01% | 947 |
|